1st Quarter - Report

TAP PHARMACEUTICAL PRODUCTS for TAP PHARMACEUTICAL PRODUCTS

Firm
Client
Income
—
Expenses
$220,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Anti-counterfeiting. Medicare and Medicaid payment policies. TRICARE.

LobbyistCovered position, as disclosed
LAURA ELIZABETH CLINE —
DEBORAH LYNN WALTER —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.